New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GSK;ACN;NYX;JBL;FOLD;SD;GOOG;MDRX;BBBY;ICE;ARRS From The Last 14 Days
Check below for free stories on GSK;ACN;NYX;JBL;FOLD;SD;GOOG;MDRX;BBBY;ICE;ARRS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
April 3, 2014
08:30 EDTICEIntercontinentalExchange reports March average daily volume down 16%
Subscribe for More Information
07:50 EDTGOOGNew Google shares land in market, Bloomberg says
Subscribe for More Information
06:29 EDTGOOGTaiwan makers: Chromebook shipments in 2014 to reach 4M-5M units, DigiTimes says
Subscribe for More Information
06:24 EDTGOOGGoogle could ship up to 11M Chromebooks worldwide by 2019, DigiTimes says
ABI Research believes Google could ship an estimated 11M Chromebooks in 2019 after shipping nearly 2.1M in 2013, reports DigiTimes. Research Analyst Stephanie Van Vactor said the device is a disruptive force to the portable PC market after finding the ASP to be $338. Reference Link
06:10 EDTGOOGGoogle's LeBeau hired by Facebook, TechCrunch reprots
Google (GOOG) product designer Mike LeBeau has been hired by Facebook (FB), TechCrunch reports. LeBeau had a hand in developing several voice-related technologies, including iPhone Voice Search, while working as a staff software engineer and product designer at Google, and was an early member of the Android team. LeBeau will become a product manager at Facebook. Reference Link
05:57 EDTICENYSE says expects IPO window to continue this year, Fortune reports
Subscribe for More Information
April 2, 2014
16:21 EDTGOOGOn The Fly: Closing Wrap
Subscribe for More Information
11:22 EDTGOOGAmazon says Fire TV remote control uses bluetooth
Subscribe for More Information
11:15 EDTGOOGAmazon says Fire TV 'three times as powerful' as Apple TV, Roku, Chromecast
09:18 EDTGSKOn The Fly: Pre-market Movers
Subscribe for More Information
08:37 EDTACNWells Fargo to hold a summit
Subscribe for More Information
07:44 EDTGSKAgenus down 9.4% after GlaxoSmithKline stops MAGRITi Phase 3 trial
Subscribe for More Information
07:23 EDTGOOGApple (AAPL) to act like Google (GOOG) in ad push, Business Insider says
Subscribe for More Information
07:15 EDTGOOGGoogle asks Supreme Court to hear 'Street View' case, Wired says
After an appeals court previously found Google may have violated the Wiretap Act with its past collection of unencrypted Wi-Fi data as part of its Street View program, the company is asking the Supreme Court to rule on the matter, reported Wired, citing court documents. Reference Link
07:14 EDTGOOGGoogle shares undervalued at current levels, says Bernstein
Subscribe for More Information
06:50 EDTGOOGYouTube dominates mobile apps, Facebook on top in mobile social, Re/code says
Subscribe for More Information
06:45 EDTGOOGAmazon expected to announce media streaming device today, Business Insider says
Subscribe for More Information
06:16 EDTGOOGGoogle April volatility elevated into 2-1 stock split and Q1
Subscribe for More Information
06:11 EDTGSKGlaxoSmithKline confirms plans to stop MAGRIT Phase III trial
GlaxoSmithKline announced its decision to stop the MAGRITi trial, a Phase III trial of its MAGE-A3ii cancer immunotherapeuticiii in non-small cell lung cancer patients, after establishing that it will not be possible to identify a sub-population of gene-signature positive NSCLC patients that may benefit from the treatment. Data from the trial announced on 20 March 2014 showed that it did not meet its first or second co-primary endpoints as it did not significantly extend disease-free survival when compared to placebo in either the overall MAGE-A3 positive population or in those MAGE-A3-positive patients who did not receive chemotherapy. The trial will be stopped and GSK will now gain access to the un-blinded data, in order to conduct a full assessment of the findings and understand learnings for other aspects of immunotherapy development within GSK. The Independent Data Monitoring Committee indicated that its review of the current safety information revealed no specific safety concern and the data is in line with the known safety information for the MAGE-A3 cancer immunotherapeutic.
05:45 EDTGSKAgenus announces GSK's MAGE-A3 Phase 3 study will be stopped
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use